JWCAR239 in Patients With B Cell Non-Hodgkin Lymphoma

NCT07024147 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

B-Cell Non-Hodgkin Lymphoma
Large B Cell Diffuse Lymphoma
Follicular Lymphoma
Marginal Zone B Cell Lymphoma
Mantle Cell Lymphoma (MCL)

Interventions

BIOLOGICAL: JWCAR239
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

Peking University Cancer Hospital & Institute

Collaborators

[object Object]